$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
图卡替尼的副作用与注意事项
2025-10-19 11:44:20
Check Details
艾拉司群的中文说明书
2025-10-19 11:44:20
Check Details
靶向药图卡替尼(Tucatinib),Tukysa的详细说明书
2025-10-19 11:44:20
Check Details
图卡替尼(Tucatinib)的用法用量:用药指南,剂量调整,特殊人群用药,用药注意事项
2025-10-19 11:44:20
Check Details
艾拉司群的说明书,医保,价格,疗效,副作用
2025-10-19 11:44:20
Check Details
艾拉司群的说明书:作用与功效,用法用量,副作用,注意事项
2025-10-19 11:44:20
Check Details
FDA加速批准图卡替尼(Tukysa)联合曲妥珠单抗用于治疗既往接受过治疗的RAS野生型、HER2阳性转移性结直肠癌患者
2025-10-19 11:44:20
Check Details
阿培利司的用药指南
2025-10-19 11:44:20
Check Details
阿培利司的副作用如何缓解
2025-10-19 11:44:20
Check Details
阿培利司的副作用与注意事项
2025-10-19 11:44:20
Check Details
阿培利司的适应症
2025-10-19 11:44:20
Check Details
卡帕塞替尼的副作用如何缓解
2025-10-19 11:44:20
Check Details
1
2
...
8135
8136
8137
8138
8139
8140
8141
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Sirolimus (Rapamune) Comprehensive Clinical Guide
5
Lusutrombopag Efficacy, Dosage and Storage Instructions
6
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
7
Cemiplimab (Libtayo) Drug Information
8
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
9
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia
10
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
11
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
12
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis